Zodwa Dlamini

Q: What Schools Are Affiliated With Zodwa Dlamini

Zodwa Dlamini is affiliated with the following schools: University of Pretoria, University of the Witwatersrand, Mangosuthu University of Technology, University of the Western Cape, University of Cape Town, University of Bristol, University of Johannesburg

Zodwa Dlamini 's AcademicInfluence.com Rankings

Zodwa Dlamini

Biology

#10792

World Rank

#14148

Historical Rank

Biochemistry

#2726

World Rank

#2912

Historical Rank

biology Degrees

Download Badge

Biology

Zodwa Dlamini 's Degrees

Bachelors Biochemistry University of Cape Town
Masters Biochemistry University of Cape Town
PhD Biochemistry University of Johannesburg

Why Is Zodwa Dlamini Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Zodwa Dlamini is a South African biochemist and Ex-deputy Vice Chancellor for Research at the Mangosuthu University of Technology. She researches molecular oncology. She is a former Vice President of the South African Medical Research Council and is a member of the Council for Scientific Advisers for the International Centre for Genetic Engineering and Biotechnology.

(See a Problem?)

Zodwa Dlamini 's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Cervical cancer in low and middle-income countries (2020) (112)
Colon cancer: genomics and apoptotic events (2004) (95)
The molecular mechanisms of oesophageal cancer. (2005) (93)
Kallikrein and Kinin Receptor Expression in Inflammation and Cancer (2001) (87)
Breast cancer in low-middle income countries: abnormality in splicing and lack of targeted treatment options. (2020) (75)
Genealogy, expression, and molecular mechanisms in apoptosis. (2004) (75)
Artificial intelligence (AI) and big data in cancer and precision oncology (2020) (72)
Upregulation of tissue kallikrein, kinin B1 receptor, and kinin B2 receptor in mast and giant cells infiltrating oesophageal squamous cell carcinoma (2005) (48)
Expression and function of retinoblastoma binding protein 6 (RBBP6) in human lung cancer. (2011) (44)
Molecular genetics of human cervical cancer: role of papillomavirus and the apoptotic cascade (2004) (37)
Molecular genetics and mechanisms of apoptosis in carcinomas of the lung and pleura: therapeutic targets. (2007) (36)
Abnormalities in alternative splicing in diabetes: therapeutic targets. (2017) (34)
De-regulation of the RBBP6 isoform 3/DWNN in human cancers (2012) (34)
Translocator Protein (TSPO) as a Potential Biomarker in Human Cancers (2018) (34)
The Role of MicroRNAs in Kidney Disease (2015) (31)
Human Immunodeficiency Virus-1 (HIV-1)-Mediated Apoptosis: New Therapeutic Targets (2014) (27)
Colorectal Cancer Genetics, Incidence and Risk Factors: In Search for Targeted Therapies (2020) (27)
African medicinal plants and their derivatives: Current efforts towards potential anti-cancer drugs. (2017) (26)
Visualisation of tissue kallikrein and kinin receptors in oesophageal carcinoma. (1999) (26)
Can the HIV-1 splicing machinery be targeted for drug discovery? (2017) (22)
Esophageal cancer in African blacks of Kwazulu Natal, South Africa: an epidemiological brief. (2005) (22)
Pyruvate dehydrogenase kinase 4 (PDK4) could be involved in a regulatory role in apoptosis and a link between apoptosis and insulin resistance. (2015) (18)
Linking the ceramide synthases (CerSs) 4 and 5 with apoptosis, endometrial and colon cancers. (2015) (18)
Abnormalities in Alternative Splicing of Apoptotic Genes and Cardiovascular Diseases (2015) (16)
Abnormalities in alternative splicing of angiogenesis-related genes and their role in HIV-related cancers (2017) (14)
The role played by alternative splicing in antigenic variability in human endo-parasites (2014) (14)
Expression analysis and association of RBBP6 with apoptosis in colon cancers (2016) (13)
A multinational review: Oesophageal cancer in low to middle-income countries (2020) (11)
Aberrant Splicing Events and Epigenetics in Viral Oncogenomics: Current Therapeutic Strategies (2021) (10)
Esophageal cancer genetics in South Africa (2019) (10)
Can targeting apoptosis resolve the cancer saga? (2005) (10)
Apoptosis in Cancer Cells Is Induced by Alternative Splicing of hnRNPA2/B1 Through Splicing of Bcl-x, a Mechanism that Can Be Stimulated by an Extract of the South African Medicinal Plant, Cotyledon orbiculata (2020) (9)
The Catastrophic HPV/HIV Dual Viral Oncogenomics in Concert with Dysregulated Alternative Splicing in Cervical Cancer (2021) (9)
Mitotic syndicates Aurora Kinase B (AURKB) and mitotic arrest deficient 2 like 2 (MAD2L2) in cohorts of DNA damage response (DDR) and tumorigenesis. (2021) (9)
MicroRNA and Alternative mRNA Splicing Events in Cancer Drug Response/Resistance: Potent Therapeutic Targets (2021) (9)
Regulation of alternative splicing in obesity-induced hypertension (2019) (8)
Splicing Genomics Events in Cervical Cancer: Insights for Phenotypic Stratification and Biomarker Potency (2021) (8)
LncRNAs and the Angiogenic Switch in Cancer: Clinical Significance and Therapeutic Opportunities (2022) (7)
Long non-coding RNAs (LncRNAs), viral oncogenomics, and aberrant splicing events: therapeutics implications. (2021) (7)
MicroRNA Interrelated Epithelial Mesenchymal Transition (EMT) in Glioblastoma (2022) (7)
Efavirenz and Lopinavir/Ritonavir Alter Cell Cycle Regulation in Lung Cancer (2020) (7)
Role of Precision Oncology in Type II Endometrial and Prostate Cancers in the African Population: Global Cancer Genomics Disparities (2022) (6)
Many Voices in a Choir: Tumor-Induced Neurogenesis and Neuronal Driven Alternative Splicing Sound Like Suspects in Tumor Growth and Dissemination (2021) (6)
Molecular evaluation of ribosomal protein L9 gene (RPL9) in lung cancer (2006) (5)
The dual protease inhibitor lopinavir/ritonavir (LPV/r) exerts genotoxic stress on lung cells. (2020) (4)
Genetic Drivers of Head and Neck Squamous Cell Carcinoma: Aberrant Splicing Events, Mutational Burden, HPV Infection and Future Targets (2021) (4)
Expression Analysis of RbBP6 in human cancers: a Prospective biomarker. (2019) (4)
RBBP6 Is Abundantly Expressed in Human Cervical Carcinoma and May Be Implicated in Its Malignant Progression (2019) (4)
Prostate cancer racial, socioeconomic, geographic disparities: targeting the genomic landscape and splicing events in search for diagnostic, prognostic and therapeutic targets. (2021) (4)
Competing Endogenous RNA (ceRNA) Networks and Splicing Switches in Cervical Cancer: HPV Oncogenesis, Clinical Significance and Therapeutic Opportunities (2022) (3)
Splicing machinery genomics events in acute myeloid leukaemia (AML): in search for therapeutic targets, diagnostic and prognostic biomarkers. (2020) (3)
AI and precision oncology in clinical cancer genomics: From prevention to targeted cancer therapies-an outcomes based patient care (2022) (3)
Abstract 1928: Characterization of the RPL9 and LIAS genes in lung tumors. (2013) (3)
Breast cancer: Small molecules targeting apoptosis, a prospective approach to safe scientific success (2012) (3)
An Integrative Genomics Approach for Associating Genome-Wide Association Studies Information With Localized and Metastatic Prostate Cancer Phenotypes (2017) (3)
Microbiomes, Epigenomics, Immune Response, and Splicing Signatures Interplay: Potential Use of Combination of Regulatory Pathways as Targets for Malignant Mesothelioma (2022) (2)
Genomics and splicing events of type II endometrial cancers in the black population: racial disparity, socioeconomic and geographical differences. (2020) (2)
Is targeting dysregulation in apoptosis splice variants in Mycobacterium tuberculosis (MTB) host interactions and splicing factors resulting in immune evasion by MTB strategies a possibility? (2020) (2)
Involvement of RbBP6 gene and apoptosis in the pathogenesis of lung cancer (2005) (2)
Role and Merits of Green Based Nanocarriers in Cancer Treatment (2021) (2)
Significant up-regulation of 1-ACBP, B-ACBP and PBR genes in immune cells within the oesophageal malignant tissue and a possible link in carcinogenic angiogenesis. (2017) (2)
Abstract 5546: Screening theRbBP6gene for abnormal alternative splicing in colon cancer (2011) (2)
Current Immunotherapeutic Treatments in Colon Cancer (2016) (2)
South African Herbal Extracts as Potential Chemopreventive Agents: Screening for Anticancer Splicing Activity. (2016) (2)
Prognostic Alternative Splicing Signatures in Esophageal Carcinoma (2021) (2)
HIV-Associated Cancer Biomarkers: A Requirement for Early Diagnosis (2021) (2)
Exploiting the Molecular Basis of Oesophageal Cancer for Targeted Therapies and Biomarkers for Drug Response: Guiding Clinical Decision-Making (2022) (1)
Genomics and molecular analysis of RPL9 and LIAS in lung cancer: Emerging implications in carcinogenesis (2021) (1)
Molecular analysis of the RbBP6 in hepatocellular carcinoma (2006) (1)
Pathway mapping reveals antiretroviral treatments' targeted cell cycle regulation in lung cancer (2020) (1)
The association of RBBP6 variant 3 expressions with apoptosis in human immunodeficiency virus-associated nephropathy (HIVAN). (2015) (1)
Efavirenz induces DNA damage response pathway in lung cancer (2020) (1)
Immunosuppressive Signaling Pathways as Targeted Cancer Therapies (2022) (1)
Beer in Health and Disease Prevention (2008) (1)
RBBP6 interactome: RBBP6 isoform 3/DWNN and Nek6 interaction is critical for cell cycle regulation and may play a role in carcinogenesis (2021) (1)
Abstract 2843: The effects of extracts of the indigenous South African plant,Tulbaghia violacea, on triple negative breast cancer cells (2021) (1)
RbBP6 gene expression in cancers (2005) (1)
1173 Expression of LASS/CerS 4 and 5 in Colon and Endometrial Cancers (2012) (0)
Abstract 3785: Telomerase RNA component lncRNA regulates hsa-miR-320 family and promotes prostate cancer metastasis (2023) (0)
The role played by alternative splicing in antigenic variability in human endo-parasites (2014) (0)
Erratum to: South African Herbal Extracts as Potential Chemopreventive Agents: Screening for Anticancer Splicing Activity. (2016) (0)
De-regulation of the RBBP6 isoform 3/DWNN in human cancers (2011) (0)
Microbiomics in Collusion with the Nervous System in Carcinogenesis: Diagnosis, Pathogenesis and Treatment (2021) (0)
Expression analysis and association of RBBP6 with apoptosis in colon cancers (2016) (0)
Evaluation of the mammalian DWNN gene product in apoptosis and CTL lysis (2000) (0)
Characterization of the RbBP6 gene in colon cancer (2005) (0)
Studies of transgenic tobacco plants containing Escherichia Coli glutathione reductase. (1996) (0)
South African medicinal plants show anti-cancer splicing activity (2014) (0)
The RbBP6 expression in uterine cervix squamous cell carcinoma (2007) (0)
The integrative bioinformatics approaches to predict the xanthohumol as anti-breast cancer molecule: Targeting cancer cells signaling PI3K and AKT kinase pathway (2022) (0)
RBBP6 is a multifunctional gene in human cancers: Role in mitosis and carcinogenesis (2016) (0)
Abstract 3820: Changes in the transcriptome of a triple negative breast cancer cell line following treatment with a water-soluble extract from the leaves of the indigenous Southern African plant Tulbaghia violacea (2023) (0)
Abstract 1265: RbBP6 Isoform 3 (DWNN) is a p53 stabilizer in arsenic trioxide-induced apoptosis in human cancer cell lines (2010) (0)
Molecular and biochemical aspects of the kallikrein-kinin system in oesophageal carcinoma. (1999) (0)
Abstract 4060: Identification of anti-neoplastic compounds on a triple negative breast cancer cell line from T. violacea (2022) (0)
Increased levels of RbBP6, in cervical cancer suggest its involvement in carcinogenesis (2005) (0)
Viral Encoded miRNAs in Tumorigenesis: Theranostic Opportunities in Precision Oncology (2022) (0)
Unraveling the Complex Interconnection between Specific Inflammatory Signaling Pathways and Mechanisms Involved in HIV-Associated Colorectal Oncogenesis (2023) (0)
Drug Standardization through Pharmacognostic Approaches and Estimation of Anticancer Potential of Chamomile (Matricaria chamomilla L.) using Prostate-Cancer cell lines: An In-vitro Study (2023) (0)
Influence of the Microbiome Metagenomics and Epigenomics on Gastric Cancer (2022) (0)
Abstract #5104: General down-regulation of the DWNN gene in human cancers (2009) (0)
Expression analysis of the translocator protein 18 kDa (Tspo) mRNA in various human normal and cancer tissues (2018) (0)
Abstract 3831: The molecular composition of a water-soluble extract from the leaves of the indigenous Southern African plant Tulbaghia violacea that displays anti-cancer activity against a triple negative breast cancer cell line (2023) (0)
ESTABLISHMENT OF A MOLECULAR GENOTYPE REFERENCE DATABASE FOR MANDARIN ACCESSION VERIFICATION (2013) (0)
The Use of Translocator protein 18 kDa (Tspo) as a Biomarker in Various Human Cancers (2018) (0)
Editorial: Cholesterol and cancer drug resistance: Molecular, signaling, and therapeutic aspects (2022) (0)
Increased levels of RbBP6 suggest an involvement in the tumorigenesis of breast cancer (2007) (0)
Reports of Plant-Derived Nanoparticles for Prostate Cancer Therapy (2023) (0)
Abstract 3248: Over-expression of 1-ACBP, B-ACBP and PBR genes in mast cells infiltrating oesophageal squamous cell tumors (2016) (0)
WITHDRAWN: Investigating the link of ceramide synthases (CerSes) 4 and 5 in endometrial and colon cancers. (2015) (0)
CMAR_A_251223 9869..9882 (2020) (0)
126 Up-regulation and accumulation of RbbP6 in oesophageal tumours (2015) (0)
Abstract 1085: RbBP6 isoform 3/DWNN is essential for arsenic trioxide-induced G2/M arrest in cancer cell lines (2010) (0)
Prostate Cancer Disparities and Management in Southern Africa: Insights into Practices, Norms and Values (2022) (0)
Editorial: Women in science: Genetics (2022) (0)
Abstract 5552: Medicinal plants show anticancer splicing activity of apoptotic genes (2015) (0)
Abstract 2156: Genomics and molecular analysis of Aurora kinase B (AURKB) in response to antiretroviral (ARV) treatment in lung cancer (2021) (0)
The profiling, identification, quantification and analysis of differentially expressed genes (DEGs) in response to drug treatment in lung cancer (2021) (0)
Genomic Interplay between Neoneurogenesis and Neoangiogenesis in Carcinogenesis: Therapeutic Interventions (2023) (0)
Abstract 2948: Anti-tumor effect of C. orbiculata is modulated by alternative splicing (2020) (0)
Multi-Omics and Management of Follicular Carcinoma of the Thyroid (2023) (0)
Maize Beer Carcinogenesis: Molecular Implications of Fumonisins, Aflatoxins and Prostaglandins (2009) (0)
1174 Association of RBBP6 With Cervical Cancer Progression (2012) (0)
Regulation of pyruvate dehydrogenase kinase 4 (PDK4) and its role in apoptosis (2008) (0)
Abstract 99: Posttranslational modification of the RBBP6 isoform 3 is required for excessive cell proliferation (2012) (0)

This paper list is powered by the following services:

Other Resources About Zodwa Dlamini

en.wikipedia.org

What Schools Are Affiliated With Zodwa Dlamini ?

Zodwa Dlamini is affiliated with the following schools:

Zodwa Dlamini 's Academic­Influence.com Rankings